🇺🇸 Romazicon in United States

FDA authorised Romazicon on 20 December 1991

Marketing authorisations

FDA — authorised 20 December 1991

  • Status: approved

FDA — authorised 12 October 2004

  • Application: ANDA076256
  • Marketing authorisation holder: HIKMA
  • Local brand name: FLUMAZENIL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 12 October 2004

  • Application: ANDA076755
  • Marketing authorisation holder: BAXTER HLTHCARE CORP
  • Local brand name: FLUMAZENIL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 12 October 2004

  • Application: ANDA076787
  • Marketing authorisation holder: HIKMA
  • Local brand name: FLUMAZENIL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 12 October 2004

  • Application: ANDA076955
  • Marketing authorisation holder: FRESENIUS KABI USA
  • Local brand name: FLUMAZENIL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 12 October 2004

  • Application: ANDA076589
  • Marketing authorisation holder: DR REDDYS
  • Local brand name: FLUMAZENIL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 3 May 2005

  • Application: ANDA077071
  • Marketing authorisation holder: SANDOZ
  • Local brand name: FLUMAZENIL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 13 May 2008

  • Application: ANDA078595
  • Marketing authorisation holder: RISING
  • Local brand name: FLUMAZENIL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 23 March 2009

  • Application: ANDA078527
  • Marketing authorisation holder: HIKMA FARMACEUTICA
  • Local brand name: FLUMAZENIL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 28 August 2012

  • Application: ANDA090584
  • Marketing authorisation holder: SAGENT PHARMS
  • Local brand name: FLUMAZENIL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

Romazicon in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Romazicon approved in United States?

Yes. FDA authorised it on 20 December 1991; FDA authorised it on 12 October 2004; FDA authorised it on 12 October 2004.

Who is the marketing authorisation holder for Romazicon in United States?

Marketing authorisation holder not available in our data.